Comparison of Standard Versus Extended Nicotine Patch Therapy for Smoking Cessation
Please see brief summary.
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Biochemically Verified 7-day Point Prevalence Abstinence
To evaluate the efficacy of standard (8-week) vs. extended (24-week) transdermal nicotine therapy.
End of Treatment (week 24)
Caryn Lerman, Ph.D.
University of Pennsylvania
United States: Institutional Review Board
|University of Pennsylvania||Philadelphia, Pennsylvania 19104|
|Tobacco Use Research Center||Philadelphia, Pennsylvania 19104|